Changes in cyanobacteria fluorescence with 75 μg/mL H₂O₂ for 5, 8, 17 and 24 days. by Emma T. Brentjens (17295999)

Subjects:

TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…(<b>C</b>) In IHC stain, P-IRE1α levels are decreased (40.8±3.5 A.U. <i>vs</i> 53.1±5.0 A.U., p<0.001, n = 6, 3 for each sex) in chronic hyperoxia exposed neonatal rat lungs by TUDCA. …”

ABT199 inhibits ALK ^mutant kinase activity and decreases it phosphorylation. by Richard Junior Zapata Dongo (17912565)

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…(D) The level of REST dramatically reduced in differentiated SH-SY5Y cells treated with GA (1 μM) or PU-H71 (50 nM) at 24 h. …”

K562 cells were treated with 40 nM of miR-214 mimics or a negative mimics control for 24 h, followed by treatment with 50 μM of hemin for 48 h. by Tipparat Penglong (164413)

Ratcheting experiments with 500 nm & 100 nm magnetic particles. by Oladunni B. Adeyiga (10164275)

“…For these experiments, particle suspensions were prepared by diluting particle stock into PBS, obtaining concentrations of ~5.1E7/mL for 500 nm and ~3.0E9/mL for 100 nm magnetic particles.…”

Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake. by Jeffrey M. McManus (7512926)

The detection of red (652–669 nm) and green (533–550 nm) fluorescence from yellow-green and violet laser excitation in control and H₂O₂-treated <i>M</i>. <i>a... by Emma T. Brentjens (17295999)

Subjects:

UPLC-DAD profile (270 nm) of phytocannabinoids in the extracts separated in C18 column. by Bruno Musetti (9527085)

Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

“…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC₅₀ = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”

Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

“…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC₅₀ = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”

Difference in changes in ODI and EQ-5D-5L scores among three groups (n = 45). by Jae-Hong Kim (124622)

Subjects:

Nicotine decreased Akt phosphorylation in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Dose- and time-dependent response of <i>M</i>. <i>aeruginosa</i> fluorescence to H₂O₂ exposure. by Emma T. Brentjens (17295999)

Subjects:

Red and green fluorescence of <i>M</i>. <i>aeruginosa</i> cells exposed to H₂O₂ over time relative to control. by Emma T. Brentjens (17295999)

Subjects:

Dose dependent changes in fluorescence from cyanobacteria treated with H₂O₂ after normalization with forward scatter. by Emma T. Brentjens (17295999)

Subjects:

Red and green fluorescence of <i>M</i>. <i>aeruginosa</i> after exposure to different wavelength light and H₂O₂ at 72 hours. by Emma T. Brentjens (17295999)

Subjects:

H₂O₂-treated <i>M</i>. <i>aeruginosa</i> forward scatter (FSC) and side scatter (SSC) relative to control. by Emma T. Brentjens (17295999)

Subjects:

<i>M</i>. <i>aeruginosa</i> treatment chemicals and doses. by Emma T. Brentjens (17295999)

Subjects:

Cyanobacteria growth of treated and control cells. by Emma T. Brentjens (17295999)

Subjects: